The global pharmaceutical industry could generate about $1.2 trillion in sales in 2025, according to Statista, and projections call for 4.7% annual growth through 2029. The cancer treatment segment ...

Which European healthcare stocks are most attractive right now? We asked Seeking Alpha analysts Edmund Ingham, Wolf Report ...

An absolute beat-down of a game took place on Sunday between the Oklahoma City Thunder and the Memphis Grizzlies. In Game 1 ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has surged by 13.73%, which has investors questioning if this is right time ...

The American Chemical Society Green Chemistry Institute Pharmaceutical Roundtable (GCIPR) is seeking proposals for research grants to advance green chemistry in the pharmaceutical industry. GCIPR ...

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Effective April 5, the United States imposed a 10% baseline tariff on imports from nearly all countries, excluding products from Canada and ...

Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Novo Nordisk has awarded a 50 million kroner ($7.6M) grant to the University of Copenhagen to develop less processed ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jody Hatcher, CEO of Morris & Dickson ...

While this Trump tariff sell-off has created bouts of historic volatility for the Dow, S&P 500, and Nasdaq, it's also paved ...